← Leaderboards
Jun Chen
Duke University
$6,274,141
Attributed
$6,274,141
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2M · FY2009–16$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$6,274,141 · 3
By mechanism
N01$4,195,558 · 1
R01$1,200,306 · 1
P01$878,277 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Lori A. Setton$15,853,009
- Adam Goode$10,484,801
- Michel Bagnat$12,156,058
- Robert D. Bowles$2,806,318
- John Martin$1,395,793
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseReceptorFoundationsStem CellsCellsPlayPreventRecoveryMedicalSafetyHematologic NeoplasmsGraft FailureGraft-Vs-Host DiseaseAnti-Infective AgentsEngraftmentGraft Versus Host Disease InductionHuman Subject ResearchDonor Lymphocyte InfusionComplicationData ManagementBasic ScienceDisease ModelEarly TreatmentClinical Application
Grant awards (13)
A Novel Nanoparticle Platelet Analogue for Radiation-Induced Thrombocytopenia$289,982
N01 · FY2016 · AI · contact PI
A Novel Nanoparticle Platelet Analogue for Radiation-Induced Thrombocytopenia$1,998,097
N01 · FY2015 · AI · contact PI
A Novel Nanoparticle Platelet Analogue for Radiation-Induced Thrombocytopenia$1,907,479
N01 · FY2014 · AI · contact PI
Developing Immature Nucleus Pulposus Cells for Regenerative Therapy$221,837
R01 · FY2013 · AR · contact PI
Prevention of GVHD by Depletion of Naive T Cells$164,264
P01 · FY2013 · CA · contact PI
Developing Immature Nucleus Pulposus Cells for Regenerative Therapy$233,513
R01 · FY2012 · AR · contact PI
Prevention of GVHD by Depletion of Naive T Cells$174,756
P01 · FY2012 · CA · contact PI
Developing Immature Nucleus Pulposus Cells for Regenerative Therapy$233,513
R01 · FY2011 · AR · contact PI
Prevention of GVHD by Depletion of Naive T Cells$174,762
P01 · FY2011 · CA · contact PI
Developing Immature Nucleus Pulposus Cells for Regenerative Therapy$243,243
R01 · FY2010 · AR · contact PI
Prevention of GVHD by Depletion of Naive T Cells$183,064
P01 · FY2010 · CA · contact PI
Developing Immature Nucleus Pulposus Cells for Regenerative Therapy$268,200
R01 · FY2009 · AR · contact PI
Prevention of GVHD by Depletion of Naive T Cells$181,431
P01 · FY2009 · CA · contact PI